PD-L1 IHC 22C3 pharmDx | 合法醫療器材資訊網

2020年5月29日—TheFDArecentlyapprovedthePD-L1IHC22C3pharmDx–P150013/S014.ThePD-L1IHC22C3pharmDx–P150013/S014isalabtestdoctorsuseto ...

We’re sorry. The page you are looking for is not available for one of the following reasons.

The link to this page may not be correct or is out-of-date. You have bookmarked a page that has moved.

Try one of these options:

Search FDA.gov Check the FDA Archive Contact FDA[1][2][3]

Or try one of these helpful links to FDA topics:

Are you sure this is the right web address? Let us know.[4]

Content current as of:

04/01/2019

References Search FDA.gov (search.usa.gov) Ch...

FDA approves atezolizumab for first | 合法醫療器材資訊網

FDA approves atezolizumab for first-line treatment of metastatic NSCLC with high ... On May 18, 2020, the Food and Drug Administration approved atezolizumab ... Read More

PD-L1 IHC 22C3 pharmDx | 合法醫療器材資訊網

2020年5月29日 — The FDA recently approved the PD-L1 IHC 22C3 pharmDx – P150013/S014. The PD-L1 IHC 22C3 pharmDx – P150013/S014 is a lab test doctors use to ... Read More

PD-L1 IHC 28-8 pharmDx | 合法醫療器材資訊網

2020年6月10日 — The PD-L1 IHC 28-8 pharmDx is a lab test doctors can use to identify if patients with non-small cell lung cancer (NSCLC) have the protein ... Read More

PD | 合法醫療器材資訊網

PD-L1 protein expression is defined as the percentage of tumor cells exhibiting positive membrane staining at any intensity. PD-L1 expression as detected by PD- ... Read More

Premarket Approval (PMA) | 合法醫療器材資訊網

Approval for the PD-L1 IHC 28-8 pharmDx for expanding the indications to squamous cell carcinoma of the head and neck, and urothelial cancer patients. Read More

Premarket Approval (PMA) | 合法醫療器材資訊網

Super Search Devices@FDA 6 ... The specimen should be considered to have PD-L1 expression if TPS >= 1% and high PD-L1 expression if TPS >= 50%. Read More

FDA Approval Timeline of Active Immunotherapies | 合法醫療器材資訊網

Timelines of FDA approvals in active immunotherapies, plus EMA, NDMA, and PDMA approvals of anti-PD-1/L1 antibody agents. Read More

FDA Approved PD | 合法醫療器材資訊網

The FDA has approved the PD-L1 (SP142) assay as a complementary diagnostic to identify PD-L1 expression levels in patients considering treatment with the ... Read More

相關資訊整理

PD-L1 IHC 22C3 pharmDx | 合法醫療器材資訊網

FDA approves atezolizumab for first | 合法醫療器材資訊網

PD-L1 IHC 22C3 pharmDx | 合法醫療器材資訊網

PD-L1 IHC 28-8 pharmDx | 合法醫療器材資訊網

PD | 合法醫療器材資訊網

Premarket Approval (PMA) | 合法醫療器材資訊網

Premarket Approval (PMA) | 合法醫療器材資訊網

FDA Approval Timeline of Active Immunotherapies | 合法醫療器材資訊網

FDA Approved PD | 合法醫療器材資訊網

【羅氏凡塔那抗ALK(D5F3)兔子單株抗體】許可證字號:衛部醫器輸字第025531號

【羅氏凡塔那PD-L1(SP263)檢驗試劑組】許可證字號:衛部醫器輸字第031811號

【萬靈達可展望試劑組】許可證字號:衛署醫器輸壹字第003118號

【"羅氏" 凡塔那PD-L1 (SP263) 單株抗體 (未滅菌)】許可證字號:衛部醫器輸壹字第017934號

【羅氏人類上皮因子接受體第2蛋白兔子單株抗體】許可證字號:衛部醫器輸字第027542號

【羅氏抗生物素單株抗體(未滅菌)】許可證字號:衛署醫器輸壹字第007333號

【達克HER2螢光原位雜交檢測套組】許可證字號:衛部醫器輸字第032407號

【萬靈達可免疫組織化學染色抗體-肌肉系列】許可證字號:衛署醫器輸壹字第005157號

【羅氏原位雜交銀染超視野檢測套組(未滅菌)】許可證字號:衛署醫器輸壹字第008337號

【羅氏抗PD-L1 (SP142) 兔單株一級抗體檢驗試劑】許可證字號:衛部醫器輸字第033118號

【萬靈泛用型染色試劑套組】許可證字號:衛署醫器輸壹字第003335號

【達可免疫螢光抗體】許可證字號:衛署醫器輸壹字第004002號

【達可“展望”染色試劑組】許可證字號:衛署醫器輸壹字第003233號

【萬靈達可一般目的反應試劑】許可證字號:衛署醫器輸壹字第005491號

【羅氏人類上皮因子接受體第2蛋白三合一異種移植物對照玻片】許可證字號:衛署醫器輸字第020386號

【"賽斯" 牙科手機及其附件(未滅菌)】許可證字號:衛署醫器輸壹字第010480號

【“都邇”放射線影片(未滅菌)】許可證字號:衛部醫器輸壹字第020871號

【舒美軟性隱形眼鏡】許可證字號:衛署醫器輸字第006003號

【3M兒童醫用口罩(未滅菌)】許可證字號:衛署醫器輸壹字第011643號

【"愛惜康" 內視鏡縫合輔助器】許可證字號:衛署醫器輸字第009509號

【"慕樂" 軀幹護具 (未滅菌)】許可證字號:衛署醫器輸壹字第002860號

【昕睫彩色二週拋式軟性隱形眼鏡】許可證字號:衛署醫器製字第002515號

【亞培輔理善越佳型醫院用血糖血酮監測儀】許可證字號:衛部醫器陸輸字第000582號

【"萬力" 搖控後荷式治療機】許可證字號:衛署醫器輸字第007480號

【"優奇"血液迴路管】許可證字號:衛署醫器輸字第012728號

【“銀谷” 醫用腰帶(未滅菌)】許可證字號:衛部醫器輸壹字第022323號

【“西門子”螺旋式電腦斷層掃描系統】許可證字號:衛署醫器輸字第022925號

【貝克曼庫爾特爾瑞 β-2-微球蛋白試劑】許可證字號:衛署醫器輸字第012209號

【“唯德康”一次性內視鏡使用注射針】許可證字號:衛部醫器陸輸字第000984號

【"晉皇" 金石型呼吸管路細菌過濾器】許可證字號:衛署醫器製字第001430號